Mobile

Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control

Update Il y a 5 ans
Reference: NCT00621140

Woman and Man

Extract

To investigate efficacy, safety and tolerability of BI 1356 versus placebo

Inclusion criteria

  • Diabetes Mellitus, Type 2

Links